Qrativ

About:

Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical.

Website: http://qrativ.bio

Top Investors: Mayo Clinic, Matrix Capital Management, Matrix

Description:

Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical need are discovered and developed. The company's platform ,Darwin.ai, identifies new uses for existing molecules for diseases with unmet medical need and uses machine learning and artificial intelligence for research and development, enabling patient to get treatments for diseases for which drugs are not available in the market.

Total Funding Amount:

$8.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

agustin(AT)nference.net

Founders:

Andrew Badley, Murali Aravamudan, Venky Soundararajan

Number of Employees:

11-50

Last Funding Date:

2017-07-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai